User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 04:29, 4 December 2020 (diff | hist) . . (-83) . . FAM230F
- 04:27, 4 December 2020 (diff | hist) . . (-85) . . FAM230E
- 04:24, 4 December 2020 (diff | hist) . . (-65) . . FAM230D
- 04:20, 4 December 2020 (diff | hist) . . (+132) . . FAM230A
- 04:12, 4 December 2020 (diff | hist) . . (+1,907) . . N FAM218A (Created page with "FAM218A (which has very little evidence of homo- logues, even in primates) is potential non-coding genes annotated with ‘protein evidence’ because of protein-protein inte...")
- 03:41, 4 December 2020 (diff | hist) . . (+2,500) . . N FAM99B (Created page with "FAM99B may serve as a tumor suppressor in HCC and may provide a promising therapy target for patients with HCC. ==Annotated Information== ===Name=== Approved symbol：FAM99B...")
- 03:32, 4 December 2020 (diff | hist) . . (+2,006) . . N FAM99A (Created page with "The alterations in the lncRNA family with sequence similarity 99 member A (FAM99A) in PE and its effects on trophoblasts. ==Annotated Information== ===Name=== Approved symbol...")
- 03:17, 4 December 2020 (diff | hist) . . (+2,361) . . N EVA1A-AS (Created page with "Hepatocellular carcinoma (HCC) specific intronic long noncoding antisense (lnc-AS) RNA, the EVA1A-AS gene, is located within the second intron (I2) of the EVA1A gene (EVA-1 ho...")
- 03:06, 4 December 2020 (diff | hist) . . (-60) . . ETS1-AS1
- 11:37, 2 December 2020 (diff | hist) . . (+120) . . EPB41L4A-DT
- 11:33, 2 December 2020 (diff | hist) . . (+2,179) . . N EMSLR (Created page with "Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis. ==Annotated Information== ===Name=== Approved symbol:EMSLR Approved name:E2F1 mRNA stabilizing...")
- 09:40, 2 December 2020 (diff | hist) . . (+1,953) . . N EGILA (Created page with "LncRNA DLGAP1 antisense RNA 2 (DLGAP1-AS2),one kind cytoplasmic long non-coding RNA,was up-regulated in glioma and was quite correlated with poor prognosis of glioma patients....")
- 09:29, 2 December 2020 (diff | hist) . . (+1,552) . . N DLGAP1-AS2 (Created page with "LncRNA DLGAP1 antisense RNA 2 (DLGAP1-AS2),one kind cytoplasmic long non-coding RNA,was up-regulated in glioma and was quite correlated with poor prognosis of glioma patients....")
- 09:19, 27 November 2020 (diff | hist) . . (+347) . . DLEU2L
- 09:01, 27 November 2020 (diff | hist) . . (+1,980) . . N DELEC1 (Created page with "The DEC1 gene is a candidate tumor suppressor in 9q3 ==Annotated Information== ===Name=== Approved symbol:DELEC1 Approved name:deleted in esophageal cancer 1 HGNC ID:HGNC:23...")
- 08:40, 27 November 2020 (diff | hist) . . (+39) . . DCXR-DT
- 08:37, 27 November 2020 (diff | hist) . . (+3,889) . . N DARS1-AS1 (Created page with "DARS-AS1, in myeloma is directly upregulated by hypoxia inducible factor (HIF)-1，play an important role in inhibiting apoptotic cell death in renal tubular cells. ==Annotat...")
- 08:03, 27 November 2020 (diff | hist) . . (+1,573) . . CT70
- 07:38, 27 November 2020 (diff | hist) . . (+29) . . CPNE8-AS1
- 07:34, 27 November 2020 (diff | hist) . . (+30) . . COMETT
- 07:31, 27 November 2020 (diff | hist) . . (+5) . . COMETT
- 07:29, 27 November 2020 (diff | hist) . . (-17) . . COMETT
- 07:25, 27 November 2020 (diff | hist) . . (+3,273) . . N COMETT (Created page with "COMET (Correlated-to-MET), a natural antisense transcript that was highly expressed in carcinomas harboring BRAF V600E mutation or RET gene rearrangements and induced the dow...")
- 02:23, 26 November 2020 (diff | hist) . . (+3,392) . . N CHROMR (Created page with "A primate-specific lncRNA ( CHROME ), elevated in the plasma and atherosclerotic plaques of individuals with coronary artery disease, that regulates cellular and systemic chol...")
- 02:11, 26 November 2020 (diff | hist) . . (+2,596) . . N CHASERR (Created page with "CHASERR, a highly conserved long noncoding RNA transcribed from a region near the transcription start site of Chd2 and on the same strand, acts in concert with the CHD2 protei...")
- 01:43, 26 November 2020 (diff | hist) . . (+53) . . CHAER1
- 01:38, 26 November 2020 (diff | hist) . . (+184) . . CFAP58-DT
- 01:25, 26 November 2020 (diff | hist) . . (+2,071) . . N CDK6-AS1 (Created page with "BALR-2 plays a functional role in the pathogenesis and/or clinical responsiveness of B-ALL ==Annotated Information== ===Name=== Approved symbol:CDK6-AS1 Approved name:CDK6 a...")
- 08:55, 25 November 2020 (diff | hist) . . (+2,299) . . N BAIAP2-DT (Created page with "cis-acting lncRNA- coding gene pairs, lnc-BAIAP2, is shown to regulate inflammatory gene expression in macro- phages stimulated with a panel of TLR ligands or infected a leadi...") (current)
- 08:13, 25 November 2020 (diff | hist) . . (+1,192) . . N B3GAT1-DT (Created page with "B3GAT1-DT is significantly associated with EFS and it is good survival lncRNAs. ==Annotated Information== ===Name=== Approved symbol:B3GAT1-DT Approved name:B3GAT1 diverget...") (current)
- 06:25, 25 November 2020 (diff | hist) . . (+1,904) . . N CALHM6-AS1 (Created page with "Suppression of CALHM6-AS1 exerts potent inhibitory effects on the development and progression of CC via blockade of the PI3K/Akt axis. ==Annotated Information== ===Name=== App...")
- 06:08, 25 November 2020 (diff | hist) . . (+169) . . BCL6-AS1 (current)
- 05:55, 25 November 2020 (diff | hist) . . (+1,601) . . N BCAN-AS1 (Created page with "BCAN-AS1 functions as a tumor suppressor in cervical carcinoma via targeting miR-769-3p/PPWD1, providing a potential promising therapeutic target for cervical carcinoma. ==Ann...") (current)
- 12:19, 24 November 2020 (diff | hist) . . (+3,257) . . N BABAM2-AS1 (Created page with "BRE-AS1 is a noncoding RNA gene antisense to the BRE (brain and reproductive organ-expressed) gene. ==Annotated Information== ===Name=== Approved symbol：BABAM2-AS1 Approved...") (current)
- 13:37, 20 November 2020 (diff | hist) . . (+27) . . BCL6-AS1
- 11:47, 20 November 2020 (diff | hist) . . (+81) . . BRE-AS1 (current)
- 10:13, 20 November 2020 (diff | hist) . . (+123) . . ARLNC1 (current)
- 08:31, 18 November 2020 (diff | hist) . . (+1,780) . . N ARHGAP42-AS1 (Created page with "”ARHGAP42“ is a smooth muscle cell (SMC)-selective, RhoA-specific GTPase activating protein that regulates blood pressure and that a minor allele single nucleotide variati...")
- 02:59, 18 November 2020 (diff | hist) . . (+69) . . AFDN-DT
- 02:47, 18 November 2020 (diff | hist) . . (+1,512) . . AFDN-DT
- 02:01, 17 November 2020 (diff | hist) . . (+270) . . N APCDD1L divergent transcript (Created page with "Approved symbol:APCDD1L-DT Approved name:APCDD1L divergent transcript HGNC ID:HGNC:27152 Previous names；APCDD1L antisense RNA 1 (non-protein coding)|APCDD1L antisense RNA...") (current)
- 01:57, 17 November 2020 (diff | hist) . . (+299) . . N AGPAT4 intronic transcript 1 (Created page with "Approved symbol:AGPAT4-IT1 Approved name:AGPAT4 intronic transcript 1 HGNC ID:HGNC:20988 Previous names:chromosome 6 open reading frame 59|non-protein coding RNA 241|AGPAT4...") (current)
- 01:42, 17 November 2020 (diff | hist) . . (+272) . . N ADGRL3 antisense RNA 1 (Created page with "==Annotated Information== ===Name=== Approved symbol:ADGRL3-AS1 Approved name：ADGRL3 antisense RNA 1 HGNC ID：HGNC:50604 Previous names：LPHN3 antisense RNA 1|adhesion...") (current)
- 01:40, 17 November 2020 (diff | hist) . . (+272) . . N ADGRA1 antisense RNA 1 (Created page with "==Annotated Information== ===Name=== Approved symbol：ADGRA1-AS1 Approved name：ADGRA1 antisense RNA 1 HGNC ID HGNC:49543 Previous names：GPR123 antisense RNA 1|adhesion...") (current)
- 01:37, 17 November 2020 (diff | hist) . . (+4) . . ADAMTSL4 antisense RNA 1 (→Name) (current)
- 01:36, 17 November 2020 (diff | hist) . . (+256) . . N ADAMTSL4 antisense RNA 1 (Created page with "==Annotated Information== ===Name=== Approved symbol：ADAMTSL4-AS1 Approved name：ADAMTSL4 antisense RNA 1 HGNC ID HGNC:32041 Previous names：chromosome 1 open reading f...")
- 01:30, 17 November 2020 (diff | hist) . . (+184) . . N ADAMTS19 antisense RNA 1 (Created page with "==Annotated Information== ===Name=== Approved symbol：ADAMTS19-AS1 Approved name：ADAMTS19 antisense RNA 1 HGNC ID：HGNC:40797 Alias symbols：RP11-346A9.1 RefSeq ID：...") (current)
- 01:25, 17 November 2020 (diff | hist) . . (+17) . . ACTR3-AS1
- 01:03, 17 November 2020 (diff | hist) . . (+264) . . N ACTN1 antisense RNA 1 (Created page with "=Annotated Information== ===Name=== Approved symbol:ACTN1-AS1 Approved name: ACTN1 antisense RNA 1 HGNC ID:HGNC:20131 Previous names: chromosome 14 open reading frame 84|AC...") (current)
- 15:43, 16 November 2020 (diff | hist) . . (+291) . . N A1BG antisense RNA 1 (Created page with "==Annotated Information== ===Name=== Approved symbol:A1BG-AS1 Approved name: A1BG antisense RNA 1 HGNC ID: HGNC:37133 Previous names: non-protein coding RNA 181|A1BG antise...") (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
